Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter/year-end 2010 financial results conference call for 8:30 a.m. ET on Thursday, February 10, 2011. The schedules for the press release and conference call are as follows:

         
-- Q4 & YE 2010 Press Release: February 10, 2011 at 7:00 a.m. ET
-- Q4 & YE 2010 Conference Call: February 10, 2011 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 366256
 

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 366256.

The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at www.incyte.com.

Incyte
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944